chrisvoncsefalvay/vaers-outcomes huggingface dataset:
The morning following vaccination I awoke suddenly from sharp, shocking electrical pain to my left calf.  The pain was intermittent but frequent.  Throughout the day, the pain moved to my left chest.  The chest pain was best described as an electrical shock.  It was frequent but intermittent for the following three months.  During the episodes, it would take my breath away and I had to stop all activity until it resolved.  As soon as symptoms started, I began taking aspirin daily at a dose of 324 mg.    I am an emergency nurse and had repeatedly witnessed the way patients were treated if they had concerns of adverse vaccine-related events.  Because of this, I did not immediately seek care regarding my symptoms.  After about 2 months of continued symptoms, I went to see my primary doctor who focused on thanking me for getting the vaccine and re-assuring me that it was completely safe.  She did an EKG, chest XR, CBC, CMP and a thyroid test.  She did not want to do a d-dimer, troponin, inflammatory markers or a holter monitor.  The tests she did run, although seemingly inadequate, were normal.  Flash forward to the present in which I now have a diagnosis of dilated cardiomyopathy with a rate-dependent, wide-complex left bundle branch block.  I have had no lifestyle habits that would have caused this and my genetic test was negative for cardiac markers.
Patient received Fluarix shot into her left deltoid without incident.  Patient asked if she could stay in the chair for a few minutes as she sometimes gets lightheaded.  Several minutes later patient fainted in her seat.  Was unresponsive to family for approximately 30 seconds and then awoke confused and tired.  911 was called, patient was evaluated and given water to drink.  EMS evaluated patient and she was able to walk out under her own power.
6/28 - Received MCV & varicella in (R) arm - localized reaction - Bright red raised 2-3 inches diameter. 7/12 Hep A (thimerosal free) (L) arm - (L) ear swelling, redness, itching.
Fever up to 101; Headache; Pain at injection site; Slight stomach upset; Fatigue; This is a spontaneous report from a contactable consumer or other non HCP (patient herself).  A 35-years-old non-pregnant female patient received bnt162b2 BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: EL3247) via an unspecified route of administration, administered in Arm Left on 05Feb2021 14:30 (at the age of 35-years-old) as 2nd dose, single dose for covid-19 immunisation. The patient had no other medical history and there were no concomitant medications. The patient previously took bnt162b2 BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: EL3247) via an unspecified route of administration, administered in Arm Left on 22Jan2021 02:30 am as 1st dose, single dose for covid-19 immunisation. The patient previously took bactrim and experienced Known allergies. The patient did not have other vaccine in four weeks and no other medications in two weeks. The patient had no COVID prior to vaccination. On 06Feb2021, at 09:30 AM, the patient experienced fever up to 101, headache, pain at injection site, slight stomach upset and fatigue. The patient did not received treatment for the events. The patient not COVD tested post vaccination. The outcome of the events was recovered on Feb2021.  Follow-up attempts completed. No further information expected.
severe low back pain and abdominal pain Narrative: severe low back pain and ab pain esp when walking or sitting.
swelling rash itch/redness quarter size 2-3 d post Varivax #2
I went to pharmacy and received an seasonal influenza shot (lot # 11849211A) and immediately after the needle was withdrawn, my arm went completely cold. It felt like it was cold, and when I said this to the NP, he touched my arm and said that my arm was physically cold. He then had me stay there until the cold feeling left. I have had multiple other flu shots over the years, and this is the first time this has ever happened. As far as I know, I am not allergic to any of the ingredients, or anything for that matter.
First night- arm very sore and itchy. day 1- hives and swollen and hot upper arm. Took Advil. That night started with 2 Benadryl every 4 hours. day 2 pain and sore arm better. Hives still spreading, swollen and itchy. Took Benadryl. Day 2 hives still there, but little better
Approximately a few weeks after my 4th dose vaccination (05/12/2022 ) I contracted COVID-19 and experienced the following symptoms: Sore Throat, Fatigue, Cold, Lost of Taste and Smell, Cough and Body Aches. I took Ibuprofen and Mucinex DM every 12 hours for treatment before I called my doctor. By the time I did call my doctor she advised me to double up my Vitamin D, also to take Zinc, Ibuprofen, Albuterol Inhaler (If necessary)-2 puffs every 4 hours. I was feeling sick the whole 2 weeks and as of today I am feeling so much better-my taste and smell are slowly coming back. I still have a bit of Nausea but that's it.
pt recv vax; swelling w/ redness at site of inject site;seen in ofc 2 days p/ vax;
delirium, behavioral issues, fever of 100.4, tachycardia (132 at presentation to ER),
On 10/6/2020, Patient came in requesting flu shot, after reviewing patient profile and consent form, administrator asked if she wanted the pneumonia vaccine as well. Patient agreed. She administered Fluzone HD and Pneumovax 23 to patient, both IMZ on the left arm. Saturday 10/10/2020, patient called pharmacy to report adverse event. Patient states she experienced "flu like symptoms that knocked her off her feet for 2 days." She reports redness on her left arm from shoulder down to the elbow. It was hot, sore, and red. She took a benadryl and tylenol like I had advised on the day of immunizations and another dose yesterday 10/9/2020. Patient is feeling better today and just calling us for feedback.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from product quality group. The reporter is the patient.  A 53-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 25Mar2021 at 10:00 as dose 1, single (Lot number: ER2613), in left arm, on 19Aug2021 at 16:15 as dose 2, single (Lot number: EW0158), in left arm and on 01Nov2021 at 13:30 as dose 3 (booster), single (Lot number: 33026BD) at the age of 52 years, in left arm for covid-19 immunisation; coviD-19 vaccine mrna (mrna 1273) (MODERNA COVID-19 VACCINE), on 01Apr2022 at 12:00 as dose 4 (booster), single (Batch/Lot number: unknown), in left arm for covid-19 immunisation. The patient's relevant medical history was not reported. There were no concomitant medications. Past drug history included: Known allergies: ceftin, reaction(s): "Drug Allergy". The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 2022, outcome "unknown" and all described as "Treatment of COVID-19". Therapeutic measures were taken as a result of drug ineffective, covid-19. Clinical information: The patient had not taken any other medication in 2 weeks. Patient was treated with Paxlovid from 28Apr2022 to 01May2022.
FELT LIKE FAINTING; BODY ACHE; CHILLS; SEVERE HEADACHE; FEVER OF 102 F; This spontaneous report received from a patient concerned a 31 year old female. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included the patient was not pregnant at the time of reporting. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 203A21A, and expiry: UNKNOWN) dose was not reported, administered on 11-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On 11-APR-2021, the subject experienced body ache. On 11-APR-2021, the subject experienced chills. On 11-APR-2021, the subject experienced severe headache. On 11-APR-2021, the subject experienced fever of 102 f. Laboratory data included: Body temperature (NR: not provided) 102 F. On 12-APR-2021, the subject experienced felt like fainting. Treatment medications (dates unspecified) included: paracetamol. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from felt like fainting on 12-APR-2021, chills on 13-APR-2021, and fever of 102 f on APR-2021, and had not recovered from severe headache, and body ache. This report was non-serious.; Sender's Comments: V0: Medical assessment comments not required as per standard procedure as the case is considered non serious.
Information has been received from a nurse practitioner concerning a 14 year old female with no pertinent medical history and no history of drug reactions/allergies in January 2007 was vaccinated with the first dose of Gardasil (yeast) (Lot # not reported) 0.5 ml injection. There was no concomitant medication. In January 2007, the evening she received her first dose of Gardasil (yeast), she experienced rapid heart beat. Medical attention was sought. She had the same experience 24 hours later. The patient has not had another experience since then. Additional information has been requested.
T103, vomiting, crying MD called gave order to give child ped DTAP @ next visit;
No known adverse events.  Client was given Bivalent vaccine rather than monovalent vaccine for first dose.
After receiving my second shot, I developed a cough, which has not gone away since the shot.  I developed the cough the next day. It is a dry hacking cough.
Patient reported tinnitus post vaccination, denied dizziness or lightheadedness. Drank water and was observed, after 15 minutes felt better and was discharged
My partner has had double Astra Zeneca, yesterday we both received a half dose booster of your Moderna.; Recieved half dose booster of Moderna; This spontaneous case was reported by a consumer and describes the occurrence of INTERCHANGE OF VACCINE PRODUCTS (My partner has had double Astra Zeneca, yesterday we both received a half dose booster of your Moderna.) and UNDERDOSE (Recieved half dose booster of Moderna) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Previously administered products included for an unreported indication: ASTRA ZENECA COMPOUND 677 (Patient had double Astra Zeneca).    On 10-Oct-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Oct-2021, the patient experienced INTERCHANGE OF VACCINE PRODUCTS (My partner has had double Astra Zeneca, yesterday we both received a half dose booster of your Moderna.) and UNDERDOSE (Recieved half dose booster of Moderna). On 10-Oct-2021, INTERCHANGE OF VACCINE PRODUCTS (My partner has had double Astra Zeneca, yesterday we both received a half dose booster of your Moderna.) and UNDERDOSE (Recieved half dose booster of Moderna) had resolved.            No concomitant medications were provided.  No treatment medications were provided.   This case was linked to MOD-2021-349089 (Patient Link).
an itchy rash on his arms, legs, and back; Initial information received on 16-Mar-2021 regarding an unsolicited valid non-serious case from a pharmacist.  This case involves a 53 years old male patient who experienced an itchy rash on his arms, legs, and back (rash pruritic), after receiving MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE [MENACTRA].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  No concomitant medication(s) was given to the patient.   On 08-Feb-2021, the patient received 0.5 ml dose of suspect MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE (lot U6827BB and expiration date :28-Feb-2022) via intramuscular route in the right deltoid for prophylactic vaccination.  On an unknown date, 3 days later, the patient developed a non-serious an itchy rash on his arms, legs, and back (rash pruritic). The patient did not experience throat swelling or shortness of breath.   The pharmacist was asking that the reaction to be considered as an allergic reaction and if the patient was safe to take the next Menactra vaccine?  No laboratory data reported.  No treatment was received by the patient. The patient was going to see the Infectious disease Doctor on 16-Mar-2021.  At the time of reporting, the outcome was unknown for the reported event. As it was reported that, it was unknown if the rash was partially gone or all of the way gone.
Received Pneumovax vaccine 10/29/04.  Developed fever 102-103 degrees, chills, nausea, vomiting, 24 hours post vaccine. Supportive care-fluids, Tylenol/Motrin. Call if worsening.
Information has been received from a registered nurse regarding a patient of unknown age and gender. On 23-OCT-2013, the patient was administered with a dose of VARIVAX (merck) (Lot # 0079AE, expiry date unknown) (Route, dosing regimen and frequency unknown) which was exposed to a temperature excursion of up to -3 degrees Centigrade. No adverse events were reported. No product quality issue was reported. This is one of the many reports received from the same source. Additional information has been requested.
Two days post 2nd dose of vax, the pt experienced shortness of breath. No treatment was given and the information received on 3/24/00 reported the symptoms resolved.
Kinrix mistakenly given to 4 month old for Dtap and IPV doses. Child had no adverse reaction after.
little trouble taking a deep breath; voice is hoarse; a bit tightness in my chest; This is a spontaneous report from a contactable consumer, the patient. A 56-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 06Apr2021 at 08:00 (at the age of 56-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had no allergies to medications, food, or other products. The patient did not receive any other medications within 2 weeks of vaccination. Prior to the vaccination, the patient had not been diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 10Apr2021, the patient experienced a little trouble while taking a deep breath, her voice was hoarse, a little bit hard to take a breath and also felt a bit tightness in her chest upon waking a couple of times. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events trouble while taking a deep breath, voice was hoarse and tightness in her chest were not resolved at this time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Tiredness; Headache; Body aches; Sore at injection site; This spontaneous pregnancy case was reported by a consumer and describes the occurrence of FATIGUE (Tiredness), HEADACHE (Headache), MYALGIA (Body aches) and VACCINATION SITE PAIN (Sore at injection site) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Pregnant.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. The patient's last menstrual period was on 01-Aug-2020 and the estimated date of delivery was 30-Apr-2021. On an unknown date, the patient experienced FATIGUE (Tiredness), HEADACHE (Headache), MYALGIA (Body aches) and VACCINATION SITE PAIN (Sore at injection site). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) during pregnancy. The delivery occurred on an unknown date, which was reported as Unknown. For neonate 1, The outcome was reported as Unknown. At the time of the report, FATIGUE (Tiredness), HEADACHE (Headache), MYALGIA (Body aches) and VACCINATION SITE PAIN (Sore at injection site) outcome was unknown.            Patient  have not been able to note if there is any change to her period she is not menstruating and still 7 weeks  postpartum..  No negative effect has been noted with patient's recently born child. The baby was born after the first dose and 4 days before the second dose.  No concomitant medication reported. No treatment information reported.  Action taken with mRNA-1273 (Moderna COVID-19 Vaccine) in response to the event was not applicable.   This case was linked to MOD-2021-068456 (Patient Link).
Tired; Horrible itchy hiveish rash on face and under chin and rash on jaw line and a little bit on collarbone; Horrible itchy hiveish rash on face and under chin and rash on jaw line and a little bit on collarbone; Horrible itchy hiveish rash on face and under chin and rash on jaw line and a little bit on collarbone; Nausea; This is a spontaneous report from a contactable consumer, the patient. A 61-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FE3592) via an unspecified route of administration in the left arm on 10Sep2021 at 17:00 (at the age of 61-years-old) as a single dose for COVID-19 immunisation. Medical history included bipolar, anxiety and known allergies to sunscreen and some other topical stuff (multiple allergies). Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included lithium (MANUFACTURER UNKNOWN), gabapentin (MANUFACTURER UNKNOWN), escitalopram oxalate (LEXAPRO) and paracetamol (TYLENOL); all for unknown indications from unknown dates and unknown if ongoing. On 11Sep2021 at 12:00 (Saturday afternoon), the patient experienced horrible itchy hiveish rash on her face and under her chin and nausea. On 13Sep2021 (Monday), after 5:00, the patient saw the rash and it was bad and the rash was on her face underneath the chin and the jaw line and a little bit on the collarbone. The patient was also tired and still nauseous. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events horrible itchy hiveish rash on face and under chin and rash on jaw line and a little bit on collarbone, nausea and tired was not recovered at the time of this report.
drug ineffective; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 72-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 28Oct2021 as dose 3 (booster), single (Lot number: 8120), in left arm and on 20May2022 as dose 4 (booster), single (Lot number: 9893) at the age of 72 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient had no relevant medical history. The patient's concomitant medications were not reported. The following information was reported: COVID-19 (medically significant) with onset Jun2022, outcome "unknown", described as "Treatment of COVID-19"; DRUG INEFFECTIVE (medically significant) with onset Jun2022, outcome "unknown". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (Jun2022) Posiitve. Therapeutic measures were taken as a result of drug ineffective, covid-19.  Additional information: The patient was taking other medications/products within 2 weeks of starting COVID-19 treatment. The patient had previously received a COVID-19 Vaccine. Reported Event: COVID tested positive. Symptoms: congestion, major runny nose, coughing, watery eyes  No follow-up attempts are possible. No further information is expected.
No adverse event; given an expired vaccine; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (given an expired vaccine) and NO ADVERSE EVENT (No adverse event) in a 57-year-old male patient who received mRNA-1273 (Spikevax) (batch no. 083B22A) for COVID-19 vaccination.     No Medical History information was reported.   On 30-Nov-2022, the patient received first dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 30-Nov-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (given an expired vaccine). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (given an expired vaccine) and NO ADVERSE EVENT (No adverse event) outcome was unknown.      For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (given an expired vaccine).    The patient was accidently administered an expired dose of the monovalent vaccine.  The vial was initially stored in the refrigerator on 30-Nov-2022 at 07:00 hours. The vial was administered on 30-Nov-2022 at 11.30 hours.  The vial had not undergone any temperature excursions.  No concomitant medication was reported. No treatment medication was reported.
Headache ,,muscle pain,, chills, nausea,,fever.  Fatigue joint pain.
This spontaneous report as received from a consumer refers to herself a 78 years old female with depression, migraines, Gastrooesophageal reflux disease (GERD), and allergy to small pox vaccine and gluten. The patient was vaccinated subcutaneously with a single dose of ZOSTAVAX (Lot# and dose not reported) "about 4 years ago" in September 2008. Concomitant medications included PROZAC, magnesium chloride, PRILOSEC, vitamins including calcium (unspecified) and cyanocobalamin, and minerals (unspecified), CENTRUM SILVER. In September 2010, "about 2 years" after the patient received ZOSTAVAX she was diagnosed with celiac disease. She broke out with "pimples" on her back, legs, and scalp as well as her face. They were painful and she continued to break out to date, just not as bad. She also fainted this week in September 2012. The patient sought for unspecified medical attention. Biopsies were performed 2 years ago, also blood work (results not reported). The patient was given aloe vera cream for treatment and avoided perfumed products and took gluten free diet. The patient's status was not reported. Additional information has been requested.
This case was reported by a other health professional via other and described the occurrence of influenza-like symptoms in a adult patient who received Shingrix for prophylaxis. On an unknown date, the patient received Shingrix at an unknown dose. On an unknown date, less than a year after receiving Shingrix, the patient experienced influenza-like symptoms. On an unknown date, the outcome of the influenza-like symptoms was unknown. It was unknown if the reporter considered the influenza-like symptoms to be related to Shingrix. Additional details were provided as follows: The age at vaccination was not reported. The patient experienced flu like for a week. The health care professional was concerned about 2nd dose compliance, as patient was worried about the symptoms reoccurring.